http://purl.org/np/RADRUiOUh6... RADRUiOUh6

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T13:08:12.626Z

http://purl.org/np/RADRUiOUh6... RADRUiOUh6

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T13:08:12.626083

Elif Ozkan

2022-10-13T13:08:12.626Z

http://purl.org/np/RADRUiOUh6... RADRUiOUh6

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

fosinopril is indicated For treating mild to moderate hypertension, use as an adjunct in treating congestive heart failure, and may be used to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. Use as adjunct to treating heart failure and may also be used in those with heart failure. Use of an adjunct to slow progression of kidney disease in those suffering from hypertension.

Elif Ozkan

2022-10-13T13:08:12.626Z